HighMark Wealth Management’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-32,266
Closed -$4.28M – 581
2026
Q2
$4.28M Buy
+32,266
New +$2.91M 1.43% 14

Other funds holding APGE

HighMark Wealth Management's APGE Position: Q3 2026 in Review

HighMark Wealth Management sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 32,266 shares — an estimated $4.28M sold.

HighMark Wealth Management first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $4.28M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

  • HighMark Wealth Management reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
  • HighMark Wealth Management sold 32,266 Apogee Therapeutics shares in Q3 2026, an estimated $4.28M.
  • HighMark Wealth Management first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
  • HighMark Wealth Management's Apogee Therapeutics position peaked at $4.28M in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.